Absolutely agree with that Titan. The risk is high but so is the reward. Waiting for trial results takes patience, but worth the wait if this works out. The multi-gene opportunity will be the icing on the cake....for Merck....if they acquire Oncosec.
News 
Market Data 
Discover 
AI
